Semantic search
From FANTOM5_SSTAR
Human (Homo sapiens)
- 10420-106C6 (colon carcinoma cell line:COLO-320)
- 10421-106C7 (adult T-cell leukemia cell line:ATN-1)
- 10422-106C8 (Burkitt's lymphoma cell line:DAUDI)
- 10425-106D2 (astrocytoma cell line:TM-31)
- 10427-106D4 (b cell line:RPMI1788)
- 10429-106D6 (acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL)
- 10431-106D8 (epidermoid carcinoma cell line:Ca Ski)
- 10434-106E2 (oral squamous cell carcinoma cell line:Ca9-22)
- 10435-106E3 (Hodgkin's lymphoma cell line:HD-Mar2)
- 10436-106E4 (signet ring carcinoma cell line:Kato III)
- 10438-106E6 (ductal cell carcinoma cell line:KLM-1)
- 10441-106E9 (synovial sarcoma cell line:HS-SY-II)
- 10442-106F1 (schwannoma cell line:HS-PSS)
- 10444-106F3 (glioblastoma cell line:A172)
- 10445-106F4
- 10446-106F5
- 10447-106F6
- 10448-106F7 (endometrial stromal sarcoma cell line:OMC-9)
- 10449-106F8 (cord blood derived cell line:COBL-a untreated)
- 10452-106G2 (cord blood derived cell line:COBL-a 24h infection(-C))
- 10453-106G3 (cord blood derived cell line:COBL-a 24h infection)
- 10454-106G4 (chronic myelogenous leukemia cell line:K562)
- 10455-106G5 (acute lymphoblastic leukemia (B-ALL) cell line:BALL-1)
- 10456-106G6
- 10457-106G7 (squamous cell lung carcinoma cell line:LC-1F)
- 10460-106H1
- 10464-106H5 (acute lymphoblastic leukemia (T-ALL) cell line:Jurkat)
- 10466-106H7
- 10467-106H8
- 10470-106I2 (gall bladder carcinoma cell line:TGBC14TKB)
- 10471-106I3 (renal cell carcinoma cell line:TUHR10TKB)
- 10474-106I6 (myeloma cell line:PCM6)
- 10475-106I7 (retinoblastoma cell line:Y79)
- 10476-106I8 (Burkitt's lymphoma cell line:RAJI)
- 10478-107A1
- 10479-107A2
- 10484-107A7 (hepatoma cell line:Li-7)
- 10485-107A8 (glioblastoma cell line:T98G)
- 10488-107B2 (ductal cell carcinoma cell line:MIA Paca2)
- 10489-107B3
- 10493-107B7 (mesothelioma cell line:ACC-MESO-1)
- 10494-107B8 (mesothelioma cell line:ACC-MESO-4)
- 10497-107C2 (endometrial carcinoma cell line:OMC-2)
- 10498-107C3
- 10501-107C6 (squamous cell lung carcinoma cell line:RERF-LC-AI)
- 10510-107D6 (osteosarcoma cell line:143B/TK^(-)neo^(R))
- 10511-107D7
- 10512-107D8
- 10513-107D9 (colon carcinoma cell line:CACO-2)
- 10517-107E4
- 10518-107E5
- 10519-107E6
- 10521-107E8
- 10522-107E9
- 10523-107F1
- 10528-107F6
- 10531-107F9
- 10532-107G1
- 10534-107G3 (acute lymphoblastic leukemia (B-ALL) cell line:NALM-6)
- 10536-107G5 (cholangiocellular carcinoma cell line:HuH-28)
- 10537-107G6
- 10540-107G9
- 10542-107H2
- 10543-107H3
- 10544-107H4 (oral squamous cell carcinoma cell line:SAS)
- 10545-107H5 (oral squamous cell carcinoma cell line:HSC-3)
- 10546-107H6
- 10547-107H7
- 10548-107H8
- 10550-107I1 (oral squamous cell carcinoma cell line:HO-1-u-1)
- 10551-107I2
- 10557-107I8
- 10558-107I9 (osteosarcoma cell line:HS-Os-1)
- 10559-108A1
- 10563-108A5 (xeroderma pigentosum b cell line:XPL 17)
- 10564-108A6
- 10566-108A8
- 10568-108B1 (mesenchymal stem cell line:Hu5/E18)
- 10574-108B7
- 10575-108B8
- 10576-108B9
- 10577-108C1
- 10578-108C2
- 10579-108C3
- 10580-108C4
- 10581-108C5
- 10582-108C6
- 10583-108C7
- 10584-108C8
- 10585-108C9
- 10586-108D1
- 10588-108D3
- 10589-108D4 (argyrophil small cell carcinoma cell line:TC-YIK)
- 10592-108D7
- 10594-108D9
- 10599-108E5
- 10600-108E6 (myxofibrosarcoma cell line:MFH-ino)
- 10611-108F8
- 10612-108F9 (gastric adenocarcinoma cell line:MKN45)
- 10613-108G1
- 10614-108G2 (gastric adenocarcinoma cell line:MKN1)
- 10617-108G5
- 10621-108G9
- 10623-108H2
- 10624-108H3 (granulosa cell tumor cell line:KGN)
- 10625-108H4
- 10629-108H8
- 10630-108H9
- 10631-108I1 (diffuse large B-cell lymphoma cell line:CTB-1)
- 10632-108I2
- 10633-108I3 (hepatoblastoma cell line:HuH-6)
- 10634-108I4
- 10635-108I5
- 10639-108I9 (serous adenocarcinoma cell line:JHOS-2)
- 10641-109A2
- 10643-109A4 (endometrioid adenocarcinoma cell line:JHUEM-1)
- 10644-109A5
- 10645-109A6
- 10647-109A8 (lens epithelial cell line:SRA 01/04)
- 10649-109B1
- 10650-109B2
- 10653-109B5
- 10658-109C1
- 10660-109C3
- 10661-109C4
- 10665-109C8
- 10669-109D3
- 10670-109D4
- 10671-109D5
- 10672-109D6
- 10673-109D7
- 10674-109D8
- 10675-109D9
- 10676-109E1
- 10677-109E2
- 10678-109E3
- 10679-109E4
- 10681-109E6
- 10684-109E9 (myxofibrosarcoma cell line:NMFH-1)
- 10685-109F1
- 10691-109F7 (meningioma cell line:HKBMM)
- 10698-109G5 (pancreatic carcinoma cell line:NOR-P1)
- 10699-109G6 (acute myeloid leukemia (FAB M7) cell line:M-MOK)
- 10700-109G7 (chondrosarcoma cell line:SW 1353)
- 10701-109G8
- 10703-109H1 (carcinoid cell line:NCI-H1770)
- 10704-109H2 (osteoclastoma cell line:Hs 706.T)
- 10706-109H4 (pleomorphic hepatocellular carcinoma cell line:SNU-387)
- 10708-109H6 (alveolar cell carcinoma cell line:SW 1573)
- 10709-109H7 (bronchioalveolar carcinoma cell line:NCI-H358)
- 10711-109H9 (fibrous histiocytoma cell line:GCT TIB-223)
- 10712-109I1 (hairy cell leukemia cell line:Mo)
- 10715-109I4 (bronchioalveolar carcinoma cell line:NCI-H650)
- 10716-109I5
- 10718-109I7 (biphenotypic B myelomonocytic leukemia cell line:MV-4-11)
- 10720-109I9
- 10723-110A3 (pharyngeal carcinoma cell line:Detroit 562)
- 10725-110A5
- 10729-110A9 (neurofibroma cell line:Hs 53.T)
- 10730-110B1 (non-small cell lung cancer cell line:NCI-H1385)
- 10731-110B2
- 10733-110B4
- 10735-110B6 (carcinoid cell line:NCI-H727)
- 10743-110C5
- 10744-110C6 (mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162)
- 10745-110C7
- 10746-110C8
- 10752-110D5 (leukemia, chronic megakaryoblastic cell line:MEG-01)
- 10753-110D6
- 10758-110E2 (fibrosarcoma cell line:HT-1080)
- 10759-110E3 (medulloblastoma cell line:ONS-76)
- 10761-110E5
- 10762-110E6
- 10763-110E7
- 10764-110E8 (acute myeloid leukemia (FAB M5) cell line:NOMO-1)
- 10765-110E9 (acute myeloid leukemia (FAB M2) cell line:NKM-1)
- 10766-110F1 (chronic myelogenous leukemia (CML) cell line:MEG-A2)
- 10767-110F2
- 10768-110F3
- 10769-110F4
- 10770-110F5 (acute myeloid leukemia (FAB M5) cell line:P31/FUJ)
- 10773-110F8
- 10775-110G1 (lymphoma, malignant, hairy B-cell cell line:MLMA)
- 10777-110G3 (NK T cell leukemia cell line:KHYG-1)
- 10778-110G4 (hepatic mesenchymal tumor cell line:LI90)
- 10781-110G7 (somatostatinoma cell line:QGP-1)
- 10788-110H5 (acute myeloid leukemia (FAB M2) cell line:Kasumi-1)
- 10789-110H6 (acute myeloid leukemia (FAB M0) cell line:Kasumi-3)
- 10792-110H9 (acute myeloid leukemia (FAB M2) cell line:Kasumi-6)
- 10795-110I3 (anaplastic large cell lymphoma cell line:Ki-JK)
- 10797-110I5 (tubular adenocarcinoma cell line:SUIT-2)
- 10801-110I9 (chronic myeloblastic leukemia (CML) cell line:KCL-22)
- 10802-111A1 (acute myeloid leukemia (FAB M7) cell line:MKPL-1)
- 10804-111A3
- 10806-111A5
- 10808-111A7 (hereditary spherocytic anemia cell line:WIL2-NS)
- 10812-111B2 (normal intestinal epithelial cell line:FHs 74 Int)
- 10813-111B3 (normal embryonic palatal mesenchymal cell line:HEPM)
- 10814-111B4
- 10818-111B8 (hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1)
- 10819-111B9 (hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2)
- 10820-111C1 (hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3)
- 10821-111C2 (B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1)
- 10822-111C3 (B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2)
- 10823-111C4 (B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3)
- 10824-111C5 (chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1)
- 10825-111C6 (chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2)
- 10826-111C7 (chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3)
- 10827-111C8 (acute myeloid leukemia (FAB M0) cell line:KG-1)
- 10828-111C9 (acute myeloid leukemia (FAB M1) cell line:HYT-1)
- 10829-111D1 (acute myeloid leukemia (FAB M3) cell line:HL60)
- 10830-111D2 (acute myeloid leukemia (FAB M4) cell line:FKH-1)
- 10831-111D3 (acute myeloid leukemia (FAB M4) cell line:HNT-34)
- 10832-111D4 (acute myeloid leukemia (FAB M4eo) cell line:EoL-1)
- 10833-111D5 (acute myeloid leukemia (FAB M4eo) cell line:EoL-3)
- 10834-111D6 (acute myeloid leukemia (FAB M5) cell line:U-937 DE-4)
- 10835-111D7 (acute myeloid leukemia (FAB M6) cell line:EEB)
- 10836-111D8 (acute myeloid leukemia (FAB M6) cell line:F-36E)
- 10837-111D9 (acute myeloid leukemia (FAB M6) cell line:F-36P)
- 10838-111E1 (medulloblastoma cell line:D283 Med)
- 10840-111E3 (plasma cell leukemia cell line:ARH-77)
- 10843-111E6 (merkel cell carcinoma cell line:MKL-1)
- 10844-111E7 (merkel cell carcinoma cell line:MS-1)
- 10845-111E8 (mesothelioma cell line:NCI-H28)
- 10847-111F1 (mesothelioma cell line:NCI-H2052)
- 10848-111F2 (mesothelioma cell line:NCI-H2452)
- 11207-116A1 (Endothelial Cells - Aortic, donor0)
- 11210-116A4 (Smooth Muscle Cells - Aortic, donor0)
- 11212-116A6 (Smooth Muscle Cells - Umbilical artery, donor0)
- 11214-116A8 (Mesenchymal stem cells - umbilical, donor0)
- 11215-116A9 (Retinal Pigment Epithelial Cells, donor0)
- 11216-116B1 (Urothelial cells, donor0)
- 11217-116B2 (Mesenchymal stem cells - adipose, donor0)
- 11218-116B3 (Mesenchymal stem cells - hepatic, donor0)
- 11219-116B4 (Mesenchymal Stem Cells - Vertebral, donor1)
- 11220-116B5 (Sebocyte, donor1)
- 11221-116B6 (Gingival epithelial cells, donor1 (GEA11))
- 11222-116B7 (Fibroblast - Gingival, donor4 (GFH2))
- 11223-116B8 (Fibroblast - Periodontal Ligament, donor4 (PL29))
- 11224-116B9 (CD14+ Monocytes, donor1)
- 11225-116C1 (CD4+ T Cells, donor1)
- 11226-116C2 (CD8+ T Cells, donor1)
- 11227-116C3 (Dendritic Cells - monocyte immature derived, donor1)
- 11228-116C4 (Dendritic Cells - plasmacytoid, donor1)
- 11229-116C5 (CD14+ monocyte derived endothelial progenitor cells, donor1)
- 11230-116C6 (Natural Killer Cells, donor1)
- 11231-116C7 (Peripheral Blood Mononuclear Cells, donor1)
- 11232-116C8 (Macrophage - monocyte derived, donor1)
- 11233-116C9 (Neutrophils, donor1)
- 11234-116D1 (Smooth Muscle Cells - Brain Vascular, donor1)